Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Viktor Pavelic"'
Autor:
Adrian F. Ochsenbein, Dorothee von Laer, Tsanan Giroglou, Bruno Eschli, Sabine Mumprecht, Daniel D. Pinschewer, Viktor Pavelic, Matthias Matter
The effect of cancer immunotherapy on the endogenous immune response against tumors is largely unknown. Therefore, we studied immune responses against murine tumors expressing the glycoprotein (GP) and/or nucleoprotein of lymphocytic choriomeningitis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d59691124c9ed8697ae6aca516bf77d
https://doi.org/10.1158/0008-5472.c.6495833
https://doi.org/10.1158/0008-5472.c.6495833
Autor:
Adrian F. Ochsenbein, Dorothee von Laer, Tsanan Giroglou, Bruno Eschli, Sabine Mumprecht, Daniel D. Pinschewer, Viktor Pavelic, Matthias Matter
Supplementary Legends 1-2 from Decreased Tumor Surveillance after Adoptive T-Cell Therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36a8b4e399b6cb8090b39c41058bfd60
https://doi.org/10.1158/0008-5472.22368146.v1
https://doi.org/10.1158/0008-5472.22368146.v1
Autor:
Adrian F. Ochsenbein, Dorothee von Laer, Tsanan Giroglou, Bruno Eschli, Sabine Mumprecht, Daniel D. Pinschewer, Viktor Pavelic, Matthias Matter
Supplementary Figure 1 from Decreased Tumor Surveillance after Adoptive T-Cell Therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::149dde859ae25bab816b8d90b0a1cc54
https://doi.org/10.1158/0008-5472.22368152
https://doi.org/10.1158/0008-5472.22368152
Autor:
Adrian F. Ochsenbein, Dorothee von Laer, Tsanan Giroglou, Bruno Eschli, Sabine Mumprecht, Daniel D. Pinschewer, Viktor Pavelic, Matthias Matter
Supplementary Figure 2 from Decreased Tumor Surveillance after Adoptive T-Cell Therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27a7e2942c1c4668b67acc751a70f6dc
https://doi.org/10.1158/0008-5472.22368149
https://doi.org/10.1158/0008-5472.22368149
Publikováno v:
European Journal of Immunology. 39:704-716
CTL are induced by two pathways, i.e. direct priming, where tumor cells present tumor antigens to naive specific CTL, and cross-priming, where professional APC cross-present captured tumor antigens to CTL. Here, we examined direct priming versus cros
Autor:
Sabine Mumprecht, Matthias S. Matter, Bruno Eschli, Viktor Pavelic, Tsanan Giroglou, Dorothee von Laer, Daniel D. Pinschewer, Adrian F. Ochsenbein
Publikováno v:
Cancer Research. 67:7467-7476
The effect of cancer immunotherapy on the endogenous immune response against tumors is largely unknown. Therefore, we studied immune responses against murine tumors expressing the glycoprotein (GP) and/or nucleoprotein of lymphocytic choriomeningitis
Publikováno v:
Blood. 108:3406-3413
Imatinib mesylate (imatinib) is a potent inhibitor of defined tyrosine kinases (TKs) and is effective in the treatment of malignancies characterized by constitutive activation of these TKs such as chronic myeloid leukemia and gastrointestinal stromal
Autor:
Adrian F. Ochsenbein, Sabine Mumprecht, Christina Claus, Matthias S. Matter, Viktor Pavelic, Christian M. Schürch
Publikováno v:
Blood
Chronic myelogenous leukemia (CML) is a malignant myeloproliferative disease arising from a hematopoietic stem cell expressing the BCR/ABL fusion protein. Leukemic and dendritic cells (DCs) develop from the same transformed hematopoietic progenitors.
Publikováno v:
European journal of immunology. 39(3)
CTL are induced by two pathways, i.e. direct priming, where tumor cells present tumor antigens to naïve specific CTL, and cross-priming, where professional APC cross-present captured tumor antigens to CTL. Here, we examined direct priming versus cro